Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 3
2014 1
2015 1
2016 2
2017 1
2018 3
2019 2
2020 4
2021 5
2022 8
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.
Carreras J, Ikoma H, Kikuti YY, Miyaoka M, Hiraiwa S, Tomita S, Kondo Y, Ito A, Nagase S, Miura H, Kawada H, Roncador G, Campo E, Hamoudi R, Nakamura N. Carreras J, et al. Among authors: kikuti yy. Virchows Arch. 2024 Apr;484(4):657-676. doi: 10.1007/s00428-024-03774-z. Epub 2024 Mar 11. Virchows Arch. 2024. PMID: 38462571
Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma.
Carreras J, Kikuti YY, Miyaoka M, Hiraiwa S, Tomita S, Ikoma H, Kondo Y, Ito A, Nagase S, Miura H, Roncador G, Colomo L, Hamoudi R, Campo E, Nakamura N. Carreras J, et al. Among authors: kikuti yy. Hematol Rep. 2023 Mar 12;15(1):188-200. doi: 10.3390/hematolrep15010020. Hematol Rep. 2023. PMID: 36975733 Free PMC article.
Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification.
Miyaoka M, Kikuti YY, Carreras J, Ito A, Ikoma H, Tomita S, Kawada H, Roncador G, Bea S, Campo E, Nakamura N. Miyaoka M, et al. Among authors: kikuti yy. Cancers (Basel). 2022 Nov 27;14(23):5849. doi: 10.3390/cancers14235849. Cancers (Basel). 2022. PMID: 36497332 Free PMC article.
9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions.
Shiraiwa S, Kikuti YY, Carreras J, Kondo Y, Ohmachi K, Ogawa Y, Kawada H, Sato S, Gion Y, Sato Y, Nakamura N, Ando K. Shiraiwa S, et al. Among authors: kikuti yy. Am J Surg Pathol. 2022 Aug 1;46(8):1017-1024. doi: 10.1097/PAS.0000000000001899. Epub 2022 Jul 18. Am J Surg Pathol. 2022. PMID: 35848760
Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel.
Carreras J, Hiraiwa S, Kikuti YY, Miyaoka M, Tomita S, Ikoma H, Ito A, Kondo Y, Roncador G, Garcia JF, Ando K, Hamoudi R, Nakamura N. Carreras J, et al. Among authors: kikuti yy. Cancers (Basel). 2021 Dec 20;13(24):6384. doi: 10.3390/cancers13246384. Cancers (Basel). 2021. PMID: 34945004 Free PMC article.
31 results